Journal of International Oncology ›› 2018, Vol. 45 ›› Issue (4): 250-252.doi: 10.3760/cma.j.issn.1673-422X.2018.04.015

Previous Articles     Next Articles

Notch signaling pathway in lung cancer and lung cancer stem cells and its inhibitors

Liu Hengyao, Zhao Guoli, Wang Fuwen, Cai Haibo, Zhang Yueying.   

  1. School of Medicine and Life Sciences, University of Ji′nanShandong Academy of Medical Sciences; Institute of Materia Medica, Shandong Academy of Medical Sciences; Key Laboratory for BiotechDrugs of National Health and Family Planning Commission; Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Ji′nan 250200, China
  • Online:2018-04-08 Published:2018-05-16
  • Contact: Zhang Yueying, Email: zhangyueying828@126.com E-mail:zhangyueying828@126.com
  • Supported by:

    National Natural Science Foundation of China (81403150); Natural Science Foundation of Shandong Province of China (ZR2014HL064); Development Project of Traditional Chinese Medical Sciences and Technology of Shandong Province (2015325); Innovation Project of Shandong Academy of Medical Sciences

Abstract: Notch signaling pathway is involved in the abnormal differentiation and selfrenewal of lung cancer stem cells. The further studies for the roles of Notch signaling pathway in the regulation of lung cancer stem cells are expected to find new targets in the diagnosis and treatment of lung cancer. Inhibitors of the Notch signaling pathway may be effective in the treatment of lung cancer. Lung cancer stem cells are thought to be a major cause of recurrence of lung cancer, therefore, targeted therapy for lung cancer stem cells may be more effective than treatment for the entire tumor.

Key words: Receptors, Notch, Lung neoplasms, Neoplastic stem cells, Inhibitors